[go: up one dir, main page]

CA2024855C - Procede et intermediaires pour la production du glucagon - Google Patents

Procede et intermediaires pour la production du glucagon

Info

Publication number
CA2024855C
CA2024855C CA 2024855 CA2024855A CA2024855C CA 2024855 C CA2024855 C CA 2024855C CA 2024855 CA2024855 CA 2024855 CA 2024855 A CA2024855 A CA 2024855A CA 2024855 C CA2024855 C CA 2024855C
Authority
CA
Canada
Prior art keywords
resin
glucagon
asp
thr
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA 2024855
Other languages
English (en)
Other versions
CA2024855A1 (fr
Inventor
Jean-Andre Gauthier
Nedumparambil A. Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Priority to CA 2024855 priority Critical patent/CA2024855C/fr
Publication of CA2024855A1 publication Critical patent/CA2024855A1/fr
Application granted granted Critical
Publication of CA2024855C publication Critical patent/CA2024855C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2024855 1990-09-07 1990-09-07 Procede et intermediaires pour la production du glucagon Expired - Fee Related CA2024855C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2024855 CA2024855C (fr) 1990-09-07 1990-09-07 Procede et intermediaires pour la production du glucagon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2024855 CA2024855C (fr) 1990-09-07 1990-09-07 Procede et intermediaires pour la production du glucagon

Publications (2)

Publication Number Publication Date
CA2024855A1 CA2024855A1 (fr) 1992-03-08
CA2024855C true CA2024855C (fr) 1997-12-09

Family

ID=4145922

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2024855 Expired - Fee Related CA2024855C (fr) 1990-09-07 1990-09-07 Procede et intermediaires pour la production du glucagon

Country Status (1)

Country Link
CA (1) CA2024855C (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101534846B (zh) 2005-11-07 2014-11-05 印第安纳大学研究及科技有限公司 显示生理学溶解性和稳定性的胰高血糖素类似物
ES2628063T3 (es) 2007-01-05 2017-08-01 Indiana University Research And Technology Corporation Análogos de glucagón que muestran una mayor solubilidad en tampones de pH fisiológicos
CA2677932A1 (fr) 2007-02-15 2008-08-21 Indiana University Research And Technology Corporation Co-agonistes des recepteurs du glucagon/glp-1
US8980830B2 (en) 2007-10-30 2015-03-17 Indiana University Research And Technology Corporation Peptide compounds exhibiting glucagon antagonist and GLP-1 agonist activity
WO2009058662A2 (fr) 2007-10-30 2009-05-07 Indiana University Research And Technology Corporation Antagonistes du glucagon
US8450270B2 (en) 2008-06-17 2013-05-28 Indiana University Research And Technology Corporation Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers
MX2010013454A (es) 2008-06-17 2011-01-21 Tion Indiana University Res And Technology Corpora Co-agonistas de receptor de glucagon/glp-1.
HUE028072T2 (en) 2008-06-17 2016-11-28 Univ Indiana Res & Tech Corp GIP-based agonists for the treatment of metabolic disease and obesity
KR20110110174A (ko) 2008-12-19 2011-10-06 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 아미드 기반 글루카곤 슈퍼패밀리 펩티드 프로드럭
IN2012DN00377A (fr) 2009-06-16 2015-08-21 Univ Indiana Res & Tech Corp
WO2011075393A2 (fr) 2009-12-18 2011-06-23 Indiana University Research And Technology Corporation Co-agonistes du récepteur du glucagon/glp-i
JP2013518115A (ja) 2010-01-27 2013-05-20 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション 代謝疾患及び肥満の治療のためのグルカゴンアンタゴニスト‐ｇｉｐアゴニスト複合体及び組成物
JP6050746B2 (ja) 2010-05-13 2016-12-21 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation Ｇタンパク質共役受容体活性を示すグルカゴンスーパーファミリーのペプチド
ES2661228T3 (es) 2010-05-13 2018-03-28 Indiana University Research And Technology Corporation Péptidos de la superfamilia de glucagón que muestran actividad de receptor nuclear de hormona
KR20130102470A (ko) 2010-06-24 2013-09-17 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 아미드계 글루카곤 슈퍼패밀리 펩티드 프로드러그
KR20130132931A (ko) 2010-12-22 2013-12-05 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Gip 수용체 활성을 나타내는 글루카곤 유사체들
US8729017B2 (en) 2011-06-22 2014-05-20 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
LT2723367T (lt) 2011-06-22 2017-08-25 Indiana University Research And Technology Corporation Bendri gliukagono/glp-1 receptoriaus agonistai
KR20140097151A (ko) 2011-11-17 2014-08-06 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 글루코코르티코이드 수용체 활성을 나타내는 글루카곤 슈퍼패밀리 펩티드
TWI599575B (zh) 2012-06-21 2017-09-21 印第安納大學科技研究公司 表現ｇｉｐ受體活性之胰高血糖素類似物

Also Published As

Publication number Publication date
CA2024855A1 (fr) 1992-03-08

Similar Documents

Publication Publication Date Title
CA2024855C (fr) Procede et intermediaires pour la production du glucagon
CA2052375C (fr) Derives de l'hormone parathyroidienne
Yajima et al. New strategy for the chemical synthesis of proteins
US7348404B2 (en) Solid-phase peptide synthesis and agent for use in such synthesis
EP1773870B1 (fr) Méthode d'obtention de dérivés peptidiques
WO2018032843A1 (fr) Procédé de synthèse de sémaglutide
BG61125B2 (bg) Циклични вазоактивни пептидни аналози
AU614734B2 (en) Synthetic ghrh analogs
KR100493795B1 (ko) 혈관활성장펩타이드유사체의합성방법
CN112912390A (zh) Glp-1类似物的制备方法
HUT55803A (en) Process for producing vip-analogues ii
US4769445A (en) Process for the solid phase synthesis of peptides which contain sulfated tyrosine
GB1590645A (en) Process for preparing hentriacontapeptide having activity in reducing blood calcium levels
CN114945580B (zh) 用于合成南吉博肽的方法
Akaji et al. Synthesis of human endothelin-1 by regioselective disulfide formation using the silyl chloride-sulfoxide system
Yajima et al. Structure-activity relationships of gastrointestinal hormones: motilin, GIP, and [27-TYR] CCK-PZ
CA1238312A (fr) Compose peptidique lineaire antigenique
US6448031B1 (en) Process for producing LH-RH derivatives
Bernard et al. Synthesis of conjugates between luteinizing hormone releasing hormone (LH‐RH) and N‐acetyl‐muramyl‐L‐alanyl‐D‐isoglutamine (MDP) models of totally synthetic vaccines
CA1339631C (fr) Methode et intermediaires pour l'obtention du fragment amide de la somatostatine
LILI et al. Studies on peptides. CLXV. Combination of a new amide-precursor reagent and trimethylsilyl bromide deprotection for the 9-fluorenylmethyloxycarbonyl-based solid-phase synthesis of chicken antral peptide
EP0056274B1 (fr) Dérivés de l'indole et procédé de préparation de peptides
CA1335403C (fr) Procede et intermediaires pour les peptides lh-rh
CA1339700C (fr) Methode et produits intermediaires pour obtenir un peptide anf
Verhaeghe et al. A new route to sequential polypeptides combining solid phase synthesis and solution peptide synthesis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed